Shots could begin next week if the FDA authorizes the vaccines and the Centers for Disease Control and Prevention recommends them as well.
Health leaders agree Biden’s foot-dragging on finding a new director during a national health crisis has demoralized the staff and sent the wrong message about the agency’s importance.
Despite federal warnings against using the drug ivermectin to treat or prevent COVID-19, the Oregon Poison Center is getting a lot of calls about it.
Evidence suggests expanded access to unproven treatments for rare diseases is more difficult to obtain than for more common illnesses.
Cognitive decline varies widely among people who have started experiencing memory and thinking problems or who are in the earliest stage of Alzheimer’s — the patients who received Aduhelm.
Scientists may have to wait many years to find out whether Aduhelm is actually effective because the drug was approved using FDA's accelerated pathway.
Prescriptions for a controversial new drug for Alzheimer's could run $56 billion a year, putting a significant financial burden on Medicare, the health insurance for the elderly.
The Food and Drug Administration in the past month has stepped up seizures of prescription drugs being sent to American customers from pharmacies in Canada and other countries, according to operators of stores in Florida that facilitate the transactions.
This article is for premium subscribers. Please sign up here for a tax-deductible subscription.
If you're a premium subscriber, sign in below.
Oregon has filed litigation against the pharmaceutical giant against Johnson & Johnson over devices that have caused hundreds of thousands of women around the globe to experience debilitating side effects.